P03.15 Site-specific immune evasion and substantial heterogeneity within entities provide evidence for personalized immunotherapy
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
P03.15 Site-specific immune evasion and substantial heterogeneity within entities provide evidence for personalized immunotherapy
Thelen, M.; Wennhold, K.; Lehmann, J.; Staib, E.; Garcia Marquez, M. A.; Lohneis, P. & Lechner, A. et al. (2020)
Journal for Immunotherapy of Cancer, 8(Suppl 2) pp. A28-A29. DOI: https://doi.org/10.1136/jitc-2020-ITOC7.54
Documents & Media
Details
- Authors
- Thelen, M.; Wennhold, K.; Lehmann, J.; Staib, E.; Garcia Marquez, M. A.; Lohneis, P.; Lechner, A.; Wagener-Ryczek, S.; Plum, P. S.; Pfister, D.; Dörr, F.; Beutner, D. ; Thangarajah, F.; Ratiu, D.; Malter, W.; Merkelbach-Bruse, S.; Bruns, C. J.; Quaas, A.; von Bergwelt-Baildon, M. S.; Schlößer, H. A.
- Issue Date
- 2020
- Journal
- Journal for Immunotherapy of Cancer
- eISSN
- 2051-1426
- Language
- English
